Luciana Borio is a Brazilian-American infectious disease physician, public health expert, and venture capitalist. She is a Senior Fellow for Global Health at the Council on Foreign Relations, and a Venture Partner at Arch Venture Partners. From 2019 to 2021, Borio was a vice president at In-Q-Tel. She previously served as director for Medical and Biodefense Preparedness at the National Security Council, acting chief scientist of the U.S. Food and Drug Administration (FDA), assistant commissioner for counterterrorism policy of the FDA, and director of FDA's Office of Counterterrorism and Emerging Threats. She is known for her work advancing clinical trials, the development of medical countermeasures for health emergencies, and the responses to domestic and international public health emergencies.September 17, 2014, U.S. House of Representatives Committee on Foreign Affairs, Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations hearing entitled “Global Efforts to Fight Ebola”; October 16, 2014, U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Oversight and Investigations hearing entitled “Examining The U.S. Public Health Response to the Ebola Outbreak;” November 19, 2014, U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health hearing entitled “Examining Medical Product Development in the Wake of the Ebola Epidemic;” February 26, 2015, U.S. Senate Committee on Health, Education, Labor and Pensions hearing entitled “Medical and Public Health Preparedness and Response: Are We Ready for Future Threats?” March 02, 2016, US House of Representatives Committee on Energy and Commerce, Subcommittee on Oversight and Investigations hearing entitled “Examining the U.S. Public Health Response to the Zika Virus.”
Early life and education Borio obtained her MD in 1996 from George Washington University. She completed her residency in 1999 in internal medicine at the Weill Cornell Medical Center and subsequently completed a combined fellowship in infectious diseases at Johns Hopkins University and critical care medicine at the National Institutes of Health. Borio serves as an adjunct assistant professor of medicine at Johns Hopkins Hospital.
Career Borio is an infectious disease physician. Prior to joining FDA's Center for Biologics Evaluation and Research in 2008, Borio was senior associate at the UPMC Center for Health Security and assistant professor of medicine at the University of Pittsburgh (2003–2008). Borio served at the United States Department of Health and Human Services as an advisor on biodefense programs (2001 to 2008), where she implemented and managed mathematical modeling projects to assess the health effects of bioterrorism on civilians and to inform medical countermeasures procurement activities for the Office of Preparedness and Response. Before leaving her role as assistant commissioner of FDA, she approved a partnership in infectious disease research with the Bill & Melinda Gates Foundation.
In 2020, Borio was appointed by the Council on Foreign Relations to serve on its Independent Task Force on Improving Pandemic Preparedness, co-chaired by Sylvia Mathews Burwell and Frances Townsend.Independent Task Force Report No. 78 – Improving Pandemic Preparedness: Lessons From COVID-19 Council on Foreign Relations, October 2020.
In 2020, she was an honoree of the Great Immigrants Award named by Carnegie Corporation of New York.
From November 9, 2020, to January 20, 2021, Borio served as one of the 13 members of the COVID-19 Advisory Board.
In 2021, she was elected to the National Academy of Medicine.
Other activities Codagenix, Member of the Scientific Advisory BoardLuciana Borio, Senior Fellow for Global Health Council on Foreign Relations, October 2020. Goldman Sachs, ConsultantLuciana Borio, Senior Fellow for Global Health Council on Foreign Relations, October 2020.
References
External links
Luciana Borio Outlines the Evolving Role of the FDA in Developing Medical Countermeasures upmchealthsecurity.org